Management of lung disease in alpha-1 antitrypsin deficiency: what we do and what we do not know

Management of lung disease in patients with alpha-1 antitrypsin deficiency (AATD) includes both non-pharmacological and pharmacological approaches. Lifestyle changes with avoidance of environmental pollutants, including tobacco smoke, improving exercise levels and nutritional status, all encompassed...

Descripción completa

Detalles Bibliográficos
Autores principales: Barjaktarevic, Igor, Campos, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8367208/
https://www.ncbi.nlm.nih.gov/pubmed/34408831
http://dx.doi.org/10.1177/20406223211010172

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8367208/
https://www.ncbi.nlm.nih.gov/pubmed/34408831
http://dx.doi.org/10.1177/20406223211010172

Ejemplares similares